TOPIC CENTER
79 Articles
Updated Oct 5, 2026
U.S.
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
Regulatory & ComplianceFDA Issues Complete Response Letter for AbbVie’s Parkinson’s Treatment… Again
4 min read • 2 years ago -
Regulatory & ComplianceNovo Nordisk Secures Approval in China for Obesity Drug Wegovy
4 min read • 2 years ago -
Regulatory & ComplianceFDA Expands Label for Sarepta’s Duchenne Gene Therapy
4 min read • 2 years ago -
Regulatory & ComplianceWuXi Shares Surge Following BIOSECURE Act’s Exclusion
4 min read • 2 years ago -
Regulatory & ComplianceFTC Supports Rule Change to Expose Anticompetitive Drug Patent Deals
4 min read • 2 years ago -
Regulatory & ComplianceFDA Releases Guidance for Platform Technology in Drug Applications
4 min read • 2 years ago -
Regulatory & ComplianceNew Joint Regulatory Plan to Streamline Biotechnology Oversight
4 min read • 2 years ago -
Regulatory & ComplianceWuXi Biologics Withdraws from 2024 BIO Convention Amid Geopolitical Tensions
4 min read • 2 years ago -
-
-
Regulatory & ComplianceTeva and Alvotech Set to Transform Humira Market with Simlandi FDA Approval
4 min read • 2 years ago -
Regulatory & ComplianceFDA Halts Neumora’s Schizophrenia Drug Trials Over Preclinical Safety Concerns
4 min read • 2 years ago
Stay Ahead in Pharma Intelligence
Join industry executives receiving our market briefings.
